PATENT CLAIM ANALYSIS

Application Number: 15903725
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["436", "501000"]

Abstract:
Devices, solutions and method capable of quantifying a clinically significant amount of antibodies within a plasma sample obtained from an individual by quantifying binding between antibodies within the sample and microbial proteins are disclosed.

Claim (Index 12):
The diagnostic device of  claim 11 , wherein the first microbial protein bound to the first surface area comprises at least a portion of at least one of RPOB, EF-G, hsp65 ATP5a and EF-Tu.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.24138
- Patent Class: 436.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12047131', '13732434', '13060399', '13459192', '11786193']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6986440607786368
- 35 USC 102 Novelty (BERT): 0.4785908839201019
- Combined Prediction Score: 0.6766387430927834
- Mean Citation Score: 210.28351400000005
- Max Citation Score: 217.84291
- Similarity Product: 158.92210208334802

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test